Exim Routes Limited (NSE:EXIMROUTES)
India · Delayed Price · Currency is INR 90.00
-6.75 (-6.98%)
At close: Oct 16, 2026
Exim Routes Revenue
In the fiscal year ending March 31, 2026, Exim Routes had annual revenue of 2.07B INR with 71.73% growth. Exim Routes had revenue of 1.14B in the half year ending March 31, 2026. That makes Exim Routes the 33,257th largest company in the world by revenue and 2,484th in India.
Revenue
2.07B
Revenue Growth
+71.73%
P/S Ratio
0.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.07B | 865.62M | 71.73% |
| Mar 31, 2025 | 1.21B | 488.11M | 67.93% |
| Mar 31, 2024 | 718.59M | 354.13M | 97.17% |
| Mar 31, 2023 | 364.46M | 285.94M | 364.18% |
| Mar 31, 2022 | 78.52M | 42.75M | 119.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Integra Essentia | 5.07B |
| Positron Energy | 4.42B |
| AVP Infracon | 4.41B |
| Integrated Personnel Services | 4.01B |
| ROX Hi-Tech | 2.03B |
| Canarys Automations | 1.98B |
| Vaidya Sane Ayurved Laboratories | 1.07B |
| DRC Systems India | 1.01B |